Assessing the relationship between skin clearance and symptom-free days in patients with psoriasis: Analysis of clinical studies of brodalumab

Background: To better understand the relationship between physician-reported measures of disease severity and patient-reported signs and symptoms of psoriasis, an analysis was conducted from clinical trials of brodalumab, a fully human anti –interleukin-17 receptor A monoclonal antibody approved for the treatment of moderate-to-severe plaque psoriasis.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research